Date of event: device thrombosis occurred one month post initial implant procedure ((b)(6) 2018).Since the exact date of event cannot be identified, (b)(6) 2018 will be determined as the date of event.A review of the manufacturing records for the device could not be conducted as lot number of the reported device was not available.According to the gore® viabahn® endoprosthesis instructions for use (ifu), device- and/or procedure-related complications and adverse events include, but are not limited to thrombosis or occlusion.
|
On (b)(6) 2018, the patient underwent endovascular repair of an occlusive lesion in the left superficial femoral artery and was implanted with non-gore manufactured bare-metal stent and a gore® viabahn® endoprosthesis (jhjr052502j with an unknown lot number).The patient tolerated the procedure.One month post initial implant procedure, the patient admitted to the hospital due to claudication.An ultrasonography was run, confirming that the existing gore® viabahn® endoprosthesis had occluded.On (b)(6) 2018, a reintervention was performed to treat the endoprosthesis occlusion.Pre-procedure angiography was run, confirming thrombosis from the proximal end of the bare-metal stent to the distal end of the gore® viabahn® endoprosthesis.Thrombectomy was performed and non-gore manufactured vascular stents were implanted inside the gore® viabahn® endoprosthesis.Thrombus partially remained, so plain old balloon angioplasty (poba) was further performed.Thrombus still existed inside the endoprosthesis, but the physician elected to monitor the patient and completed the reintervention procedure.
|